Guanting Li

Visting Scholar

Research interest

Self-assembled prodrug nanosystem

Work Experience

guantingli@126.com

Education Background

Ph.D., Pharmaceutics, Shenyang Pharmaceutical University, 2021-2024

M.Sc., Pharmaceutics, Shenyang Pharmaceutical University, 2018-2021

B.Sc., Pharmacy, Shenyang Pharmaceutical University, 2014-2018

1. Li, G., Sun, B., Li, Y., Luo, C., He, Z., & Sun, J. (2021). Small-molecule prodrug nanoassemblies: an emerging nanoplatform for anticancer drug delivery. Small, 17(52), 2101460.

2. Li, G., Sun, B., Zheng, S., Xu, L., Tao, W., Zhao, D., ... & Sun, J. (2021). Zwitterion-driven shape program of prodrug nanoassemblies with high stability, high tumor accumulation, and high antitumor activity. Advanced Healthcare Materials, 10(23), 2101407.

3. Li, G., Xia, F., Xiao, H., Zheng, S., Fu, S., Qiao, H., ... & Sun, B. (2023). Fine-tuning the structure-tolerance-antitumor efficacy axis of prodrug nanoassemblies via branched aliphatic functionalization. Nano Research, 1-11.

4. Li, G., Jin, Q., Xia, F., Fu, S., Zhang, X., Xiao, H., ... & Sun, B. (2023). Smart stimuli-responsive carrier-free nanoassembly of SN38 prodrug as efficient chemotherapeutic nanomedicine. Acta Materia Medica, 2(1), 54-63.

5. Fu, S#., Li, G#., Zang, W., Zhou, X., Shi, K., & Zhai, Y. (2022). Pure drug nano-assemblies: A facile carrier-free nanoplatform for efficient cancer therapy. Acta Pharmaceutica Sinica B, 12(1), 92-106.

6. Zheng, S#., Li, G#., Shi, J., Liu, X., Li, M., He, Z., ... & Kamei, K. I. (2023). Emerging platinum (IV) prodrug nanotherapeutics: A new epoch for platinum-based cancer therapy. Journal of Controlled Release, 361, 819-846.

7. Zheng, S.#, Li, G.#, Fu, S., Wang, N., Qiao, H., Li, M., ... & Sun, J. (2024). Hybrid nanoassembly indicating a synthetic lethality relationship induces mitotic catastrophe-mediated tumor elimination. Chemical Engineering Journal, 479, 147802.